文献速递消化道肿瘤放疗放疗物理与技术

局部晚期胰腺癌治疗相关淋巴细胞减少恢复的预后意义

Significance of lymphocyte recovery from treatment-related lymphopenia in locally advanced pancreatic cancer.
PubMed 文献 · Radiother Oncol · 2020-07-15

该研究纳入497例接受同步放化疗的局部晚期胰腺癌患者,按急性重度淋巴细胞减少(ASL)的发生与恢复分为三组。结果显示ASL恢复者总生存与无进展生存优于未恢复者,基线淋巴细胞计数和靶区体积可预测ASL发生与恢复。

要点

  • ASL恢复者2年OS为31.9%,未恢复者仅14.6%。
  • ASL恢复与更优OS(HR 0.42)和PFS(HR 0.53)相关。
  • 基线淋巴细胞计数和靶区体积预测ASL发生与恢复。

核心结论

  • 局部晚期胰腺癌同步放化疗后ASL恢复与更优OS和PFS相关。
  • 基线淋巴细胞计数和靶区体积与ASL发生及恢复独立相关。

研究设计与样本

  • 回顾性评估497例接受同步放化疗的局部晚期胰腺癌患者。
  • 按ASL发生与恢复分为无ASL组(A组,n=198)、ASL恢复组(B组,n=141)和ASL未恢复组(C组,n=89)。
  • 采用Cox回归分析确定OS和PFS的预后因素。

主要发现

  • A、B、C组2年OS率分别为40.4%、31.9%、14.6%。
  • A、B、C组2年PFS率分别为23.7%、18.4%、10.1%。
  • A组与B组OS和PFS相当,C组OS和PFS较差(p < 0.001)。
  • ASL恢复与更优OS相关(HR 0.42,95% CI: 0.32-0.55,p < 0.001)。
  • ASL恢复与更优PFS相关(HR 0.53,95% CI: 0.41-0.70,p < 0.001)。

临床怎么用

  • 监测局部晚期胰腺癌同步放化疗患者淋巴细胞计数变化。
  • 关注ASL恢复情况以辅助预后评估。
  • 基线淋巴细胞计数和靶区体积可用于识别ASL高风险患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Radiation-induced lymphopenia is associated with poor prognosis in resected pancreatic cancer and locally advanced pancreatic cancer. However, whether lymphocyte recovery contributes to pancreatic cancer prognosis has not been well-investigated. MATERIALS AND METHODS: We evaluated 497 locally advanced pancreatic cancer patients who underwent concurrent chemoradiotherapy (CCRT). Complete blood counts of patients were obtained before, during, and after CCRT until the 12-month follow-up visit. Patients were categorized into 3 groups according to the development of and recovery from acutte severe lymphopenia (ASL): no ASL (group A, n = 198), recovery from ASL (group B, n = 141), and no recovery from ASL (group C, n = 89). Prognostic factors of overall survival (OS) and progression-free survival (PFS) were determined using Cox regression analyses. RESULTS: In groups A, B, and C, the 2-year OS rates were 40.4%, 31.9%, and 14.6%, respectively, and the 2-year PFS rates were 23.7%, 18.4%, and 10.1%, respectively. OS and PFS were comparable between Groups A and B, while group C had poor OS and PFS (p < 0.001). Recovery from ASL was associated with superior OS (HR 0.42, 95% CI: 0.32-0.55, p < 0.001) and PFS (HR 0.53, 95% CI: 0.41-0.70, p < 0.001). The baseline lymphocyte counts and target volume independently predicted development and recovery from ASL. CONCLUSION: Recovery from ASL was associated with both superior OS and PFS in patients who received CCRT for locally advanced pancreatic cancer. Baseline lymphocyte counts and target volume were associated with both the development of and recovery from treatment-related ASL.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Lee BM, Byun HK, Seong J, et al. Significance of lymphocyte recovery from treatment-related lymphopenia in locally advanced pancreatic cancer. Radiother Oncol. 2020. PMID: 32681928. doi:10.1016/j.radonc.2020.07.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。